Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04595422 · ClinicalTrials.gov registry record · NA
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
A NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT04595422: Recruiting NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.
NCT04595422 is a NA study of Lung Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 800 participants, below the 5,023-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04595422, a NA study of Lung Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
Primary Outcome
Will be content analyzed using Atlas.ti qualitative software according to the adaptation framework from Stirman and colleagues. Will identify 1) who made the modification; 2) what was modified (i.e., content, context, training and evaluation); 3) for whom the modification was made (e.g., individual counselor); 4) context of the modification (e.g., format, setting, personnel, population); and 5) what was the nature of the modification (e.g., adding elements). Will also code for facilitators and b
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- OTHER Educational Intervention
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2020-07-02 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT04595422 shows while recruiting
NCT04595422 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 5,023-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT04595422 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04595422 about?
NCT04595422 is a clinical study titled "Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines". This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
What is the current status of trial NCT04595422?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2020-07-02. Estimated completion is 2026-10-31.
What conditions does trial NCT04595422 study?
This clinical trial studies the following conditions: Lung Carcinoma.
What interventions are being tested in trial NCT04595422?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT04595422?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04595422 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04595422's enrollment target sits among peer trials
800 6th of 38 higher than 32 of 38 other Lung Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
RECRUITING · NA
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI